Lazard Asset Management
RIGL icon

Lazard Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Lazard Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,965
Closed -$255K – 2053
2025
Q4 		$255K Sell
5,965
-11,591
-66% -$437K ﹤0.01% 1572
2025
Q3 		$497K Sell
17,556
-139,444
-89% -$4.17M ﹤0.01% 1350
2025
Q2 		$2.94M Buy
157,000
+22,637
+17% +$429K ﹤0.01% 886
2025
Q1 		$2.42M Buy
134,363
+103,523
+336% +$2.1M ﹤0.01% 904
2024
Q4 		$518K Buy
30,840
+10,828
+54% +$208K ﹤0.01% 1356
2024
Q3 		$323K Buy
+20,012
New +$235K ﹤0.01% 1503
2024
Q2 		– Sell
-328
Closed -$4K – 2397
2024
Q1 		$4K Sell
328
-4,287
-93% -$57.8K ﹤0.01% 1910
2023
Q4 		$66K Buy
+4,615
New +$47.2K ﹤0.01% 1813
2023
Q2 		– Sell
-3,984
Closed -$52K – 2499
2023
Q1 		$52K Buy
+3,984
New +$63.3K ﹤0.01% 1780
2022
Q4 		– Sell
-4,141
Closed -$48K – 2537
2022
Q3 		$48K Buy
+4,141
New +$56K ﹤0.01% 1811
2021
Q3 		– Sell
-1,709
Closed -$74K – 2267
2021
Q2 		$74K Hold
1,709
– – ﹤0.01% 1437
2021
Q1 		$58K Buy
+1,709
New +$67.7K ﹤0.01% 1377
2020
Q3 		– Sell
-2,566
Closed -$46K – 1720
2020
Q2 		$46K Buy
+2,566
New +$46.2K ﹤0.01% 1250
2020
Q1 		– Sell
-735
Closed -$15K – 1715
2019
Q4 		$15K Buy
+735
New +$15.1K ﹤0.01% 1309

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management's RIGL Position: Q1 2026 in Review

Lazard Asset Management sold out of Rigel Pharmaceuticals (RIGL) in Q1 2026, closing a stake of 5,965 shares — an estimated $255K sold.

Lazard Asset Management first reported a position in RIGL in Q4 2019 and held it in 14 quarters. The position peaked at $2.94M in Q2 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Lazard Asset Management reported no remaining Rigel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Lazard Asset Management sold 5,965 Rigel Pharmaceuticals shares in Q1 2026, an estimated $255K.
  • Lazard Asset Management first reported a position in Rigel Pharmaceuticals in Q4 2019 and held it in 14 quarters.
  • Lazard Asset Management's Rigel Pharmaceuticals position peaked at $2.94M in Q2 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.